EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics

Jelena Klawitter, Bruce E Kirkpatrick iD, Ryan Shillingburg, Jost Klawitter iD, Garrett Wheeler, Touraj Shokati, Melissa A Cadnapaphornchai iD, Jeffrey L Galinkin, Joshua M Thurman iD, Uwe Christians iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jelena Klawitter und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University of Colorado, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Metabolomics, Allografts, Adaptation, Physiological. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development (NICHD), National Institute of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

End-stage kidney disease is preferably treated by kidney transplantation. The function of the allograft often determines kidney-controlled processes and requires long-term monitoring. Kidneys are organs with a very high metabolic rate, and, thus, a metabolomics approach is suitable to observe systemic metabolic changes that are related to graft adaptation. To understand these ongoing changes in post-transplant pediatric patients, we applied a targeted liquid chromatography/tandem mass spectrometry-based metabolomics approach. Time-dependent changes of 140 metabolites in plasma samples prospectively collected from 23 pediatric kidney graft recipients receiving tacrolimus-based immunosuppression were monitored over the first 4 years after transplantation and compared to levels prior to transplantation. Furthermore, by comparing the pre-transplant metabolite levels to those measured in healthy children, we were able to obtain insights into the pathways associated with kidney failure. Arginine biosynthesis, alanine, aspartate, glutamine, and glutamate metabolism, taurine and tryptophan metabolism were the most affected pathways that separate the pediatric patients with and without kidney failure. Accumulation of uremic toxins such as various tryptophan/kynurenine and tryptophan/indole metabolism pathway intermediates, and betaine and methionine cycle metabolites was evident in patients with restricted kidney function. Furthermore, reduced nicotinamide production, insufficient hydroxylation of phenylalanine to tyrosine, lowered cysteine, arginine, glutamine, taurine, and overall amino acid utilization, as well as diminished levels of protective antioxidants such as glutathione and vitamins B6 and C, were all the result of progressive kidney failure leading to transplantation. Importantly, following kidney transplantation and recovery of kidney function, the levels of most of the previously described metabolites normalized toward the levels observed in healthy participants. The here identified metabolic patterns could be used as markers to monitor the progression of pediatric chronic kidney disease patients towards kidney failure, and assuming their direct association with kidney function, they could serve as markers of successful graft adaptation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationMetabolomicsAllograftsAdaptation, PhysiologicalKidney Failure, ChronicHumansChildMaleFemaleAdolescentChild, PreschoolBiomarkersMetabolomeTransplantation, HomologousTandem Mass SpectrometryTacrolimus

Stichwörter der Autor:innen

kidney failurekidney transplantmetabolomicspediatric patientstacrolimus

Substanzen

BiomarkersTacrolimus

Autor:innen und Institutionen

  • Department of Anesthesiology, University of Colorado, Aurora, CO 80045, USA.
  • Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Emergency Department, University of Tennessee Medical Center, Knoxville, TN 37920, USA.
  • HepQuant, LLC, Denver, CO 80237, USA.
  • Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • US Anesthesia Partners of Colorado, Greenwood Village, CO 80111, USA.

ORCID-Profile: Bruce E Kirkpatrick, Jost Klawitter, Melissa A Cadnapaphornchai, Joshua M Thurman, Uwe Christians

Förderung

  • NICHD NIH HHS
  • National Institute of Child Health and Human Development (NICHD)
  • National Institute of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)

Zitieren

APA

Klawitter, J., Kirkpatrick, B. E., Shillingburg, R., Klawitter, J., Wheeler, G., Shokati, T., Cadnapaphornchai, M. A., Galinkin, J. L., Thurman, J. M., & Christians, U. (2025). Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189190

Vancouver

Klawitter J, Kirkpatrick BE, Shillingburg R, Klawitter J, Wheeler G, Shokati T, et al. Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189190

BibTeX
@article{Klawitter2025,
  author = {Klawitter, Jelena and Kirkpatrick, Bruce E and Shillingburg, Ryan and Klawitter, Jost and Wheeler, Garrett and Shokati, Touraj and Cadnapaphornchai, Melissa A and Galinkin, Jeffrey L and Thurman, Joshua M and Christians, Uwe},
  title = {Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189190}
}
Kostenlos starten →